Cargando…

Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial

Despite recent advances in the treatment of children with acute megakaryoblastic leukemia (AMKL) using intensified treatment protocols, clear prognostic indicators, and treatment recommendations for this acute myeloid leukemia (AML) subgroup are yet to be defined. Here, we report the outcome of 97 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schweitzer, Jana, Zimmermann, Martin, Rasche, Mareike, von Neuhoff, Christine, Creutzig, Ursula, Dworzak, Michael, Reinhardt, Dirk, Klusmann, Jan-Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488462/ https://www.ncbi.nlm.nih.gov/pubmed/25913479 http://dx.doi.org/10.1007/s00277-015-2383-2

Ejemplares similares

Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012
por: Rasche, Mareike, et al.
Publicado: (2018)

Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group
por: Rasche, Mareike, et al.
Publicado: (2021)

Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
por: Rasche, Mareike, et al.
Publicado: (2021)

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004
por: Rasche, M, et al.
Publicado: (2017)

Mutated WT1, FLT3-ITD, and NUP98-NSD1 Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid Leukemia
por: Niktoreh, Naghmeh, et al.
Publicado: (2019)

Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004
por: Bochennek, K, et al.
Publicado: (2016)

RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group
por: Sendker, Stephanie, et al.
Publicado: (2023)

LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia
por: Emmrich, Stephan, et al.
Publicado: (2014)

Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome
por: Grimm, Juliane, et al.
Publicado: (2021)

Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group
por: Niktoreh, Naghmeh, et al.
Publicado: (2019)

PB1813: REGULATORY MECHANISMS AND THERAPEUTIC POTENTIAL OF THE DLK1-DIO3 LOCUS IN PEDIATRIC ACUTE MEGAKARYOBLASTIC LEUKEMIA
por: Verboon, Lonneke, et al.
Publicado: (2023)

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS^
por: Bertrums, Eline J.M., et al.
Publicado: (2021)

Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration
por: Hammer, Anne Sofie Borg, et al.
Publicado: (2022)

Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
por: Schmidt, Franziska, et al.
Publicado: (2022)

Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia
por: Schumich, Angela, et al.
Publicado: (2019)

Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group
por: Benetton, Maddalena, et al.
Publicado: (2022)

Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP‐BFM acute lymphoblastic leukemia protocol
por: Jung, Mareike, et al.
Publicado: (2020)

Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
por: Knörr, Fabian, et al.
Publicado: (2021)

Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia With Unusual Immunophenotype
por: Koulmane Laxminarayana, Sindhura Lakshmi, et al.
Publicado: (2023)

Gene Expression Profiles Associated with Pediatric Relapsed AML
por: Bachas, Costa, et al.
Publicado: (2015)

A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager
por: Olatunji, Philip O, et al.
Publicado: (2018)

An Unusual Case of Myeloperoxidase-Positive Acute Megakaryoblastic Leukemia
por: Lee, Hyeyoung, et al.
Publicado: (2015)

Neonatal acute megakaryoblastic leukemia mimicking congenital neuroblastoma
por: Kawasaki, Yukako, et al.
Publicado: (2015)

Acute Megakaryoblastic Leukemia with t(1;22) Mimicking Neuroblastoma in an Infant
por: Gökçe, Müge, et al.
Publicado: (2015)

Coexistence of myelodysplastic syndrome and acute megakaryoblastic leukemia: An aggressive disease
por: Kasinathan, Ganesh, et al.
Publicado: (2021)

PB1788: A SCREENING OF DONATED CHEMICAL PROBES TO IDENTIFY NOVEL THERAPEUTIC OPTIONS FOR ACUTE MYELOID LEUKEMIA (AML) IN CHILDHOOD
por: Laszig, Stephanie, et al.
Publicado: (2023)

The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
por: Dalle, Jean-Hugues, et al.
Publicado: (2020)

Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models
por: Thiollier, Clarisse, et al.
Publicado: (2012)

Therapy-Related Acute Megakaryoblastic Leukemia in a Lung Cancer Patient
por: Moon, Jung Joo, et al.
Publicado: (2014)

Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis
por: Bernau, Ksenija, et al.
Publicado: (2015)

Clinical Characteristics and Prognosis of 27 Patients with Childhood Acute Megakaryoblastic Leukemia
por: Qi, Haixiao, et al.
Publicado: (2020)

Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study
por: Brouwer, Nienke, et al.
Publicado: (2022)

Structure-function analysis of the role of megakaryoblastic leukemia 1 in megakaryocyte polyploidization
por: Reed, Fiona E., et al.
Publicado: (2022)

Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia—A population‐based analysis of the Austrian ALL‐BFM Study Group
por: Poyer, Fiona, et al.
Publicado: (2022)

Long noncoding RNAs as regulators of pediatric acute myeloid leukemia
por: Neyazi, Sina, et al.
Publicado: (2022)

Acute Megakaryoblastic Leukemia Developing as Donor Cell Leukemia after Umbilical Cord Blood Transplantation
por: Adachi, Yoshitaka, et al.
Publicado: (2017)

Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter
por: Sendker, Stephanie, et al.
Publicado: (2021)

miR-99a/100∼125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFβ and Wnt signaling
por: Emmrich, Stephan, et al.
Publicado: (2014)

Acute mono-megakaryoblastic leukemia associated with extreme thrombocytosis and complex karyotype abnormalities
por: Hu, Rong, et al.
Publicado: (2013)

ANP32A dysregulation contributes to abnormal megakaryopoiesis in acute megakaryoblastic leukemia
por: Sun, Xueqin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4k8h0dcog5nq6p8md5vm12g2m3